Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Xconomy
JUNE 10, 2016
The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. —If Jim Greenwood railing like King Lear in the storm isn’t entertaining enough, two notorious biotech characters have once again inspired the imagination of creative types.
67 
Let's personalize your content